Evasion of Immune Responses to Introduced Human Acid α-Glucosidase by Liver-Restricted Expression in Glycogen Storage Disease Type II-Reference-Cited by-同舟云学术

Evasion of Immune Responses to Introduced Human Acid α-Glucosidase by Liver-Restricted Expression in Glycogen Storage Disease Type II

Published:2005-11 Issue:5 Volume:12 Page:876-884
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Franco Luis M.,Sun Baodong,Yang Xiaoyi,Bird Andrew,Zhang Haoyue,Schneider Ayn,Brown Talmage,Young Sarah P.,Clay Timothy M.,Amalfitano Andrea,Chen Y.T.,Koeberl Dwight D.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference48 articles.

1. The Metabolic and Molecular Basis for Inherited Disease;Hirschhorn,2001

2. Sequence of the cDNA and 5′-flanking region for human acid alpha-glucosidase, detection of an intron in the 5′ untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequences;Martiniuk;DNA Cell Biol.,1990

3. Characterization of the human lysosomal alpha-glucosidase gene;Hoefsloot;Biochem. J.,1990

4. Murine acid alpha-glucosidase: cell-specific mRNA differential expression during development and maturation;Ponce;Am. J. Pathol.,1999

5. Structural and functional-changes of lysosomal acid alpha-glucosidase during intracellular-transport and maturation;Wisselaar;J. Biol. Chem.,1993

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurological glycogen storage diseases and emerging therapeutics;Neurotherapeutics;2024-09

2. Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy;Molecular Diagnosis & Therapy;2024-08-12

3. Restoring immune balance with Tregitopes: A new approach to treating immunological disorders;Biomedicine & Pharmacotherapy;2024-08

4. Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liver;JCI Insight;2024-05-16

5. Advances in Immune Tolerance Induction in Enzyme Replacement Therapy;Pediatric Drugs;2024-04-25